240 related articles for article (PubMed ID: 17619531)
21. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax.
Spencer EB; Cohen DT; Darcy MD
J Vasc Interv Radiol; 2002 Apr; 13(4):385-90. PubMed ID: 11932369
[TBL] [Abstract][Full Text] [Related]
22. [Refractory hydrothorax in primary biliary cirrhosis: successful treatment with transjugular intrahepatic portosystemic stent shunt].
Nolte W; Figulla HR; Ringe B; Wiltfang J; Münke H; Hartmann H; Pausch J; Ramadori G
Dtsch Med Wochenschr; 1997 Oct; 122(42):1275-80. PubMed ID: 9378063
[TBL] [Abstract][Full Text] [Related]
23. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
24. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
[TBL] [Abstract][Full Text] [Related]
25. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax.
Strauss RM; Martin LG; Kaufman SL; Boyer TD
Am J Gastroenterol; 1994 Sep; 89(9):1520-2. PubMed ID: 8079930
[TBL] [Abstract][Full Text] [Related]
26. [Treatment by porto-systemic intrahepatic shunt for refractory hydrothorax during cirrhosis].
Péron JM; Dupuis E; Alric L; Ottal P; Rousseau H; Barange K; Payen JL; Pascal JP; Vinel JP
Gastroenterol Clin Biol; 1999 Mar; 23(3):414-5. PubMed ID: 10384353
[No Abstract] [Full Text] [Related]
27. [A case of refractory hepatic hydrothorax that was not treated by transjugular intrahepatic portosystemic shunt].
Park HW; Huh W; Kim SJ; Shin WC; Choi WC; Lee JH
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):327-30. PubMed ID: 12499792
[TBL] [Abstract][Full Text] [Related]
28. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
[TBL] [Abstract][Full Text] [Related]
29. [A case of refractory hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt].
Kidokoro H; Kanazawa H; Nachi T; Narahara Y; Osada Y; Mamiya Y; Kimura Y; Taki Y; Atsukawa M; Nakatsuka Y; Kuroda H; Sakamoto C
Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):707-12. PubMed ID: 12833867
[No Abstract] [Full Text] [Related]
30. [Hepatic hydrothorax: presentation of 3 cases with different therapeutic approaches].
Ortega Quiroz RJ; Moscote Granadillo M; Díaz Hernández A; Spath Spath A; Rodríguez María R; Reyes Romero A; Cure Cuse A; Estrada Redondo C; Cucunuba Toloza A
Rev Gastroenterol Peru; 2019; 39(1):64-69. PubMed ID: 31042238
[TBL] [Abstract][Full Text] [Related]
31. Management of refractory hepatic hydrothorax.
Porcel JM
Curr Opin Pulm Med; 2014 Jul; 20(4):352-7. PubMed ID: 24811830
[TBL] [Abstract][Full Text] [Related]
32. Hepatic hydrothorax: pathogenesis, diagnosis, and management.
Lazaridis KN; Frank JW; Krowka MJ; Kamath PS
Am J Med; 1999 Sep; 107(3):262-7. PubMed ID: 10492320
[TBL] [Abstract][Full Text] [Related]
33. Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature.
Badillo R; Rockey DC
Medicine (Baltimore); 2014 May; 93(3):135-142. PubMed ID: 24797168
[TBL] [Abstract][Full Text] [Related]
34. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.
Malinchoc M; Kamath PS; Gordon FD; Peine CJ; Rank J; ter Borg PC
Hepatology; 2000 Apr; 31(4):864-71. PubMed ID: 10733541
[TBL] [Abstract][Full Text] [Related]
35. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
Wallace MJ; Madoff DC; Ahrar K; Warneke CL
Cancer; 2004 Jul; 101(2):337-45. PubMed ID: 15241832
[TBL] [Abstract][Full Text] [Related]
36. Parallel TIPS for treatment of refractory ascites and hepatic hydrothorax.
Parvinian A; Gaba RC
Dig Dis Sci; 2013 Oct; 58(10):3052-6. PubMed ID: 23625294
[No Abstract] [Full Text] [Related]
37. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Haskal ZJ; Zuckerman J
Chest; 1994 Oct; 106(4):1293-5. PubMed ID: 7924523
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion.
Tan HK; James PD; Sniderman KW; Wong F
J Gastroenterol Hepatol; 2015 Feb; 30(2):389-95. PubMed ID: 25168607
[TBL] [Abstract][Full Text] [Related]
39. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
40. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
